Effect of SLN containing finasteride on anderogenic alopecia
- Conditions
- anderogenic alopecia.Androgenic alopecia
- Registration Number
- IRCT20181128041780N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 50
Men with Androgenic Alopecia Based on Hamilton's Criteria. Stage 2-4
Completing the consent form
No endocrine disease (diabetes), thyroid disorders, systemic diseases including lupus, other cases, including arthritis and cicatrisil (associated with scar), history of skin or systemic malignancy, psychiatric disorders, skin disorders Head skulls other than those with AGASerious Cardiovascular Diseases, Kidney Disease, Liver Disease
No use of zinc and iron supplements, malnutrition, iron deficiency anemia
Non-use of medications leads to hair loss, including anti-hypertensive and anti-inflammatory drugs, NSAIDs
No history of alcohol consumption or substance abuse
No history of finasteride in the last 6 months and minoxidil in the past month
No history of drug hypersensitivity, breast disorders, surgical history for the treatment of hair loss
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The number of hair from short hair in 1 cm square in the area of assessment in the Vertex hairless part. Timepoint: At the beginning of the work and weeks 8, 16 and 24. Method of measurement: Using the computer scan obtained from macrophotography images of the marked area, it is evaluated for hair growth.
- Secondary Outcome Measures
Name Time Method 1- Evaluation of the frequency of local skin complications including: erythema-burning-itchy-folliculitis-clinical diagnosis by the assessor. Timepoint: At the beginning of the work and weeks 8, 16 and 24. Method of measurement: 1-Measuring erythema and itching and burning with a visual analogue scale and evaluating folliculitis clinically and by assessor.;2. Quality of life assessment. Timepoint: At the beginning of the work and weeks 8, 16 and 24. Method of measurement: 2. Assessing the quality of life ,the basis of the WAA-QOL benchmark.